Wildcat Capital Management, LLC

In its 13F for Q1 2026 (holdings as of March 31, 2026, filed May 1, 2026), Wildcat Capital Management, LLC reported 2 stock positions worth $106.2 million. Its top holding was Frontier (ULCC) at 93.3% of the portfolio, followed by Allogene Therapeutics (ALLO, 6.7%). Compared with Q4 2025, it sold out of 1. The biggest sale was an exit from Procore Technologies (PCOR).

Most Recent 13F
Q2 2026
Location
NEW YORK, NY
CIK
0001582384
Portfolio Value
$106.2M (Q1 2026)
SEC Filing
0001999371-26-009738 ↗ filed May 1, 2026

Holdings Value

0$100.0M$200.0M$300.0M$400.0M$500.0M Q1 2024: $275.5M Q1 2024 Q2 2024: $408.6M Q2 2024 Q3 2024: $204.6M Q3 2024 Q4 2024: $252.7M Q4 2024 Q1 2025: $187.4M Q1 2025 Q2 2025: $168.3M Q2 2025 Q3 2025: $145.1M Q3 2025 Q4 2025: $136.5M Q4 2025 Q1 2026: $106.2M $106.2M Q1 2026 Q2 2026: $228.5M Q2 2026

Holdings 2 stocks · $106.2M
ULCC Frontier Group Holdings Inc. 93.29% 28,061,351 $99.1M No change
ALLO Allogene Therapeutics Inc. 6.71% 2,920,787 $7.1M No change

Portfolio Sells Q4 2025 → Q1 2026
PCOR Procore Technologies Inc. Sold out 0.00% −0.21

Portfolio Buys Q4 2025 → Q1 2026
None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 3$228.5MULCC, ALLO, CHYM
Q1 2026 2$106.2MULCC, ALLO
Q4 2025 3$136.5MULCC, ALLO, PCOR
Q3 2025 5$145.1MULCC, RLX, ALLO, TTAN, GTLB
Q2 2025 6$168.3MULCC, RLX, TIC, URGN, ALLO
Q1 2025 8$187.4MULCC, RLX, TIC, URGN, ALLO
Q4 2024 8$252.7MULCC, RLX, ALLO, URGN, KRON
Q3 2024 7$204.6MULCC, RLX, ALLO, URGN, SKILLZ INC
Q2 2024 16$408.6MULCC, FYBR, MCO, MSFT, RLX
Q1 2024 16$275.5MFYBR, GSHD, MCO, MSFT, RLX